Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 4/20 | 0.61 |
| ▸ | CACNB4 | O00305 | 2/20 | 0.61 |
| ▸ | CACNA1A | O00555 | 2/20 | 0.61 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.61 |
| ▸ | CACNG3 | O60359 | 2/20 | 0.61 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.61 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.61 |
| ▸ | CACNB3 | P54284 | 2/20 | 0.61 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4055917 | 0.84 | KMT2A (0.56) | KMT2A | |
| SCHEMBL18287218 | 0.82 | KMT2A (0.63) | KMT2A | |
| SCHEMBL137420 | 0.81 | KDM4E (0.61) | MAPTLMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL136259 | 0.80 | KDM4E (0.60) | MAPTLMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL620485 | 0.80 | GABRP (0.66) | MAPTLMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL135158 | 0.80 | KDM4E (0.60) | MAPTLMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL4057593 | 0.80 | KMT2A (0.53) | KMT2A | |
| SCHEMBL4061107 | 0.80 | KMT2A (0.53) | KMT2A | |
| SCHEMBL99056 | 0.79 | — | — | |
| SCHEMBL15976546 | 0.78 | ALDH1A1 (1.00) | MAPTLMNASMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1671973-A2 | Allosteric adenosine receptor modulators | King Pharmaceuticals Research and Development, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1390740-A4 | METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A 1? ADENOSINE RECEPTOR LIGANDS FOR THE A 1? ADENOSINE RECEPTOR | ENDACEA INC (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-1671973-A2 | Allosteric adenosine receptor modulators | King Pharmaceuticals Research and Development, Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1025106-B1 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | KING PHARMACEUTICALS RES & DEV (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20040121406-A1 | Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor | ENDACEA, INC. | 2004-06-24 | — | — | US | disclosed |
| EP-1390740-A1 | METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A 1? ADENOSINE RECEPTOR LIGANDS FOR THE A 1? ADENOSINE RECEPTOR | Endacea, Inc. (US) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002095391-A1 | METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A1 ADENOSINE RECEPTOR LIGANDS FOR THE A1 ADENOSINE RECEPTOR | ENDACEA INC. (US) | 2002-11-28 | — | — | WO | disclosed |
| US-6323214-B1 | CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS AND ANALGESICS | MEDCO RESEARCH, INC | 2001-11-27 | — | — | US | disclosed |
| US-6194449-B1 | ADMINISTERING A BENZOYLTHIOPHENE COMPOUND; ANTIHYPOXIC, ANTIISCHEMIC AGENTS | MEDCO CORP. | 2001-02-27 | — | — | US | disclosed |
| US-6177444-B1 | ANTIISCHEMIC AGENTS; ANTIARRHYTHMIA AGENTS | MEDCO CORP. | 2001-01-23 | — | — | US | disclosed |
| EP-1025106-A2 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | Medco Research, Inc. (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999021617-A2 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | MEDCO RESEARCH, INC. (US) | 1999-05-06 | — | — | WO | disclosed |